May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Involvement of Endothelial Precursors from Bone Marrow in Pterygium
Author Affiliations & Notes
  • Y. Song
    Ophthalmology,
    Chung–Ang Univ.Yong–San Hosp., Seoul, Republic of Korea
  • M. Kim
    Pathology,
    Chung–Ang Univ.Yong–San Hosp., Seoul, Republic of Korea
  • J. Kim
    Ophthalmology,
    Chung–Ang Univ.Yong–San Hosp., Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Y. Song, None; M. Kim, None; J. Kim, None.
  • Footnotes
    Support  research funds (code : stem cell 13) from the 21C frontier research program
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2936. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Song, M. Kim, J. Kim; Involvement of Endothelial Precursors from Bone Marrow in Pterygium . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2936.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We evaluated the involvement of endothelial precursors and its related activating factors in pterygium, then measured chemotactic factors both locally and systemically before and after operation. And also we confirmed increased mobilization of endothelial progenitors from bone marrow. Methods: Primary (n=15), recurrent pterygium (n=10) and normal control cases (n=5) were selected for this research. Immunohistochemical staining with endothelial precursor markers (CD31, CD34, c–kit, VEGF–R1(Flt–1) and VEGF–R2(Flk–1)) and related factors (hypoxia inducible factor–1α (HIF–1α), NF–ΚB and VEGF) were performed. Their producing site was examined, too. Chemotactic factors (IL–1ß, GM–CSF, VEGF and substance–P) were measured in patient’s tear and serum by using ELISA on pre operation and post operation 1st, 3rd and 5th day. To confirm the mobilization of endothelial precursors systemically, flowcytometry of peripheral blood with CD34 and c–kit was also done. Results: The CD31, c–kit and Flt–1 positive endothelial precursor cells were revealed coincidently in stroma, which were clustered around small vessels and formed rosette pattern. These foci were increased remarkably in recurrent pterygium compared to in primary pterygium. HIF–1α, as producing factor of VEGF was observed mainly in epithelium. NF–ΚB was expressed co–localized with HIF–1α in nucleus. Substance–P was increased on 1st day and VEGF was elevated from 3rd day of operation in ELISA with serum and tear. These activating factors were increased more significantly in recurrent pterygium. The CD34 and c–kit positive endothelial precursors were increased on 3rd∼5th day of operation especially in recurrent cases. Conclusions: Co–expressed CD31, c–kit and Flt–1 could be applied as marker of endothelial precursor. Above results demonstrate that endothelial precursors from bone marrow were involved in pathogenesis and recurrence of pterygium. This involvement was mediated by chemotactic factors in both locally and systemically.

Keywords: Pterygium • immunohistochemistry • flow cytometry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×